Hjem › Mesoteliom
Mesoteliom kliniske forsøg rekrutterer i USA
45 studier for Mesoteliom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX15 studier
- New York City, NY10 studier
- Washington, DC9 studier
- Chicago, IL9 studier
- Nashville, TN8 studier
- Boston, MA8 studier
- Arlington, VA6 studier
- Philadelphia, PA6 studier
- Pittsburgh, PA6 studier
- Seattle, WA6 studier
- Los Angeles, CA6 studier
- Columbus, OH5 studier
- Rochester, MN5 studier
- Edison, NJ5 studier
- San Antonio, TX4 studier
- San Diego, CA4 studier
- Tampa, FL4 studier
- St. Louis, MO4 studier
- Phoenix, AZ4 studier
- Jacksonville, FL4 studier
- Queens, NY4 studier
- Dallas, TX4 studier
- Omaha, NE4 studier
- Grand Rapids, MI3 studier
- Denver, CO3 studier
- Detroit, MI3 studier
- Santa Monica, CA3 studier
- Mountain View, CA3 studier
- East Norwalk, CT3 studier
- Staten Island, NY3 studier
- Greenburgh, NY3 studier
- New Rochelle, NY3 studier
- Miami, FL3 studier
- Santa Rosa, CA3 studier
- Fort Worth, TX3 studier
- Durham, NC3 studier
Efter delstat
- Arizona7 studier
- Californien12 studier
- Colorado8 studier
- Florida12 studier
- Georgia3 studier
- Illinois11 studier
- Kansas3 studier
- Maryland10 studier
- Massachusetts10 studier
- Michigan6 studier
- Minnesota8 studier
- Missouri5 studier
- Nebraska4 studier
- New Jersey8 studier
- New York11 studier
- North Carolina4 studier
- Ohio9 studier
- Pennsylvania13 studier
- Tennessee8 studier
- Texas19 studier
- Utah4 studier
- Virginia8 studier
- Washington6 studier
- Wisconsin3 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
SW-682 in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06251310Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
RekruttererObservationsstudie
Alder 2 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT00242723Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RekruttererObservationsstudie
Alder 2 til 100 · Alle køn · Opdateret 2. okt. 2026 · NCT01950572Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT06885697Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
RekruttererObservationsstudie
Alder 2 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT03830229Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT05932199Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 30 til 120 · Alle køn · Opdateret 28. sep. 2026 · NCT04431024A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07277413Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT04981119Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Rekrutterer
Alder 30 til 85 · Alle køn · Opdateret 24. sep. 2026 · NCT06037941A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06057935Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
RekruttererFase 2
Alder 18 til 120 · Alle køn · Opdateret 23. sep. 2026 · NCT05960773A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07705334Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT06566079TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04969315Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT05245500A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT04104776Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
RekruttererFase 1
Alder 18 til 79 · Alle køn · Opdateret 4. aug. 2026 · NCT07192900Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT05579366Lead-212 PSV359 Therapy for Patients With Solid Tumors
RekruttererFase 1/2
Alder 18 til 90 · Alle køn · Opdateret 6. jul. 2026 · NCT06710756Integrated Cancer Repository for Cancer Research
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 24. jun. 2026 · NCT05568680CT-95 in Advanced Cancers Associated With Mesothelin Expression
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT06756035A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT06051695Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.